HSN Code 30029090: Blood Products & Biologics | Other

HSN Code 30029090 represents Blood Products & Biologics | Other under GST classification. This code helps businesses identify Blood Products & Biologics | Other correctly for billing, taxation, and trade. With HSN Code 30029090, companies can avoid errors in invoices, simplify compliance, and enable hassle-free import or export of Blood Products & Biologics | Other.

Live Demo Available Today

Experience the power of Expert Accounting

Join our guided walkthrough to see how BUSY can transform your business operations.

Trusted by 6,00,000+ Users
4.6 Google Rating
+91
expand_more

* No credit card required

Description of Goods for HSN Code 30029090

HSN Code 30029090 relates to the following description.

Description of Goods

Other : Other

Chapter

30 - Pharmaceutical products

Sub Chapter

3002 - Human blood; animal blood prepared fortherapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines,toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified

CGST

6%

SGST

6%

IGST

12%

CESS

0%

What does HSN Code 30029090 not include?

Blood Products & Biologics | Other does not include products with the following descriptions.

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for diptheria

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : for snake venom

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : antisera : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : hemoglobin blood globulins and serum globulins

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : of human origin

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes : other : other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For diphtheria

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For tetanus

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For rabies

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Antisera; For Snake venom

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : antisera: Other

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale:

Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale

Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : Immunological products, put up in measured doses or in forms or packings for retail sale

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for cholera and typhoid

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for hepatitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tetanus

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for polio

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for tuberculosis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for rabies

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for japanese encephalitis

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : for whopping cough (pertusis)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine : single vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria, pertusis and tetanus (dpt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for diphtheria and tetanus (dt)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for measles, mumps and rubella (mmr)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : for typhoid-paratyphoid (tab) or typhoid- paratyphoid-cholera (tabc)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Cholera and typhoid

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Hepatitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tetanus

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Polio

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Tuberclosis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Rabies

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Japanese encephalitis

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Whopping cough (pertussis)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Single vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria, pertussis and tetanus (DPT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Diphtheria and tetanus (DT)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Measles, mumps and rubella (MMR)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid (TAB)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Typhoid-paratyphoid-cholera (TABC)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine: Mixed vaccines for: Other

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for veterinary medicine

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Cultures of micro-organisms (excluding yeast)

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Toxins

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other

Other : Animal blood prepared for therapeutic, prophylactic or diagnostic uses

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : cultures of micro-organisms (excluding yeast)

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products other : toxins

India’s Trade Performance — HSN Code 30029090 in FY 2024-25

TradeStat EIDB — Ministry of Commerce & Industry FY 2018-19–FY 2024-25 Values in ₹ Crore

India’s Exports

FY 2024-25

₹198 Cr

−16.86% vs FY 2023-24

0.0054% of India’s total exports

India’s Imports

FY 2024-25

₹70 Cr

−44.17% vs FY 2023-24

0.0012% of India’s total imports

Trade Balance

FY 2024-25

₹127 Cr

Trade Surplus

Surplus rank #1439 of 12657 HSN codes

% of Sub-Chapter 3002

FY 2024-25

1.31%

Share of Sub-Chapter 3002’s total exports in FY 2024-25

Import side: 0.64% of Sub-Chapter 3002’s imports

Rank Within Sub-Chapter 3002

FY 2024-25

#12 of 61

Position by export value among HSN codes in Sub-Chapter 3002

Import-side rank: #12 of 61

At a glance

5.06%

Export CAGR

FY 2018-19 → FY 2024-25 · 7 fiscal years

#1861

National Export Rank

of 12657 HSN codes by export value, FY 2024-25

+451.79%

Peak Growth Year

FY 2021-22 · strongest single-year move

1.31%

Contribution to Sub-Ch. 3002

Share of Sub-Chapter 3002 exports in FY 2024-25

India Export-Import Trade Statistics for HSN Code 30029090

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

FY 2018-19 Exp. Rank #1604

Balance

−53.70

Exports

147.02 ₹ Cr

0.0064% share

YoY

2.40% of Sub-Ch. 3002

Imports

200.72 ₹ Cr

0.0056% share

YoY

3.78% of Sub-Ch. 3002

FY 2019-20 Exp. Rank #1953

Balance

−122.68

Exports

104.98 ₹ Cr

0.0048% share

−28.59% YoY

1.41% of Sub-Ch. 3002

Imports

227.66 ₹ Cr

0.0068% share

+13.42% YoY

3.31% of Sub-Ch. 3002

FY 2020-21 Exp. Rank #1490

Balance

+25.33

Exports

176.17 ₹ Cr

0.0082% share

+67.81% YoY

1.94% of Sub-Ch. 3002

Imports

150.84 ₹ Cr

0.0052% share

−33.74% YoY

1.77% of Sub-Ch. 3002

FY 2021-22 Exp. Rank #470

Balance

−346.20

Exports

972.08 ₹ Cr

0.0310% share

+451.79% YoY

8.90% of Sub-Ch. 3002

Imports

1,318.28 ₹ Cr

0.0288% share

+773.96% YoY

14.47% of Sub-Ch. 3002

FY 2022-23 Exp. Rank #1314

Balance

+99.66

Exports

305.29 ₹ Cr

0.0084% share

−68.59% YoY

2.59% of Sub-Ch. 3002

Imports

205.63 ₹ Cr

0.0036% share

−84.40% YoY

2.46% of Sub-Ch. 3002

FY 2023-24 Exp. Rank #1610

Balance

+111.93

Exports

237.81 ₹ Cr

0.0066% share

−22.10% YoY

1.71% of Sub-Ch. 3002

Imports

125.88 ₹ Cr

0.0022% share

−38.78% YoY

1.47% of Sub-Ch. 3002

FY 2024-25 Exp. Rank #1861

Balance

+127.44

Exports

197.72 ₹ Cr

0.0054% share

−16.86% YoY

1.31% of Sub-Ch. 3002

Imports

70.28 ₹ Cr

0.0012% share

−44.17% YoY

0.64% of Sub-Ch. 3002

CAGR · 7-Year

Exports

5.06% /yr

Imports

−16.05% /yr

Consistently Surplus
Sub-Chapter 3002 total

reference, FY 2024-25

Export

₹15,063.17 Cr

Import

₹11,034.41 Cr

Trade Balance

+4,028.76

Peak export growth year Latest available data Not available YoY = change vs previous FY

Key Trade Insights: HSN Code 30029090 Export-Import Analysis

Consistent Export Growth: 5.06% CAGR Over 7 Years

India's exports under HSN Code 30029090 have grown at a compound annual rate of 5.06% over 7 fiscal years, rising from ₹147.02 Crore in FY 2018-19 to ₹197.72 Crore in FY 2024-25.

HSN Code 30029090 Ranked #1861 Among All 12657 HSN codes by Export Value

In FY 2024-25, HSN Code 30029090 ranks #1861 out of 12657 HSN codes by total export value. Within Sub-Chapter 3002, it ranks #12 of 61. By trade surplus, it ranks #1439 of 12657.

FY 2021-22 Was the Strongest Growth Year for HSN Code 30029090 Exports

The strongest single-year export movement for HSN Code 30029090 was recorded in FY 2021-22, when exports surged by 451.79% over the prior year.

India Maintains a Trade Surplus of ₹127.44 Crore in HSN Code 30029090 Goods

In FY 2024-25, India's exports of ₹197.72 Cr exceeded imports of ₹70.28 Cr, resulting in a trade surplus of ₹127.44 Crore — ranking #1439 of 12657 by surplus magnitude.

Import Growth of −16.05% CAGR Signals Stable Import Dependency for Blood Products & Biologics | Other

India's imports under HSN Code 30029090 have grown at −16.05% CAGR, reaching ₹70.28 Crore in FY 2024-25.

HSN Code 30029090 Contributes 1.31% of Sub-Chapter 3002 Exports — Ranked #12

Among the 61 HSN codes under Sub-Chapter 3002, HSN Code 30029090 ranks #12 by export value — accounting for 1.31% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 0.64% share (rank #12).

Stop worrying about HSN & TAX compliance

BUSY auto-applies the correct HSN codes & GST rates, ensuring 100% error-free billing every single time.

Automatic Updates
Error-free GSTR
6,00,000+ Happy Users
+91
expand_more

* No credit card required

Frequently Asked Questions

Clear answers to common queries about HSN Code 30029090 and GST compliance.

What products are classified under HSN 30029090 ?

It includes Blood Products & Biologics | Other

Does packaging or labelling change the GST for Blood Products & Biologics / Other?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

Can we claim ITC on inputs used to trade Blood Products & Biologics / Other?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

How should mixed supplies be billed when Blood Products & Biologics / Other is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Blood Products & Biologics / Other; Nil for exempt items if applicable).

Do e‑way bill and e‑invoice apply for Blood Products & Biologics / Other?

e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies.

How much GST applies to Blood Products & Biologics / Other?

Under HSN 30029090, Blood Products & Biologics / Other attracts Varies when sold in taxable form. Describe the exact form on the invoice.

Important Disclaimer

The above does not constitute professional advice or a formal recommendation. We recommend consulting a professional tax consultant before acting on the information contained in this piece of content.